Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS–CoV-2
CONCLUSION Pediatric patients with SARS–CoV-2 are at risk for critical illness with severe COVID-19 and MIS-C. Cytokine profiling and examination of peripheral blood smears may distinguish between patients with MIS-C and those with severe COVID-19.FUNDING Financial support for this project was provided by CHOP Frontiers Program Immune Dysregulation Team; National Institute of Allergy and Infectious Diseases; National Cancer Institute; the Leukemia and Lymphoma Society; Cookies for Kids Cancer; Alex’s Lemonade Stand Foundation for Childhood Cancer; Children’s Oncology Group; Stand UP 2 Cancer; Team Connor; the Kate Amato Foundations; Burroughs Wellcome Fund CAMS; the Clinical Immunology Society; the American Academy of Allergy, Asthma, and Immunology; and the Institute for Translational Medicine and Therapeutics.
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Caroline Diorio, Sarah E. Henrickson, Laura A. Vella, Kevin O. McNerney, Julie Chase, Chakkapong Burudpakdee, Jessica H. Lee, Cristina Jasen, Fran Balamuth, David M. Barrett, Brenda L. Banwell, Kathrin M. Bernt, Allison M. Blatz, Kathleen Chiotos, Brian T Source Type: research
More News: Academies | Acute Leukemia | Allergy | Allergy & Immunology | Asthma | Biomedical Science | Cancer | Cancer & Oncology | Childhood Cancer | Children | Coronavirus | COVID-19 | Hematology | Infectious Diseases | Leukemia | Lymphoma | Pandemics | Papanicolaou (Pap) Smear | Pediatrics | Respiratory Medicine